TD Cowen Upgrades Cardinal Health to Buy, Raises Price Target to $144
Cardinal Health Analyst Ratings
TD Cowen Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $144
Evercore Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $140
Evercore ISI Group Upgrades Cardinal Health to Outperform, Maintains Price Target to $140
B of A Securities Upgrades Cardinal Health to Buy, Raises Price Target to $145
Cardinal Health Analyst Ratings
BofA Securities Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $145
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $136
Cardinal Health Analyst Ratings
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $136
Cardinal Health Raised to Equal-Weight From Underweight by Wells Fargo
Cardinal Health Analyst Ratings
Wells Fargo Upgrades Cardinal Health(CAH.US) to Hold Rating, Raises Target Price to $127
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $149
Jefferies Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $125
J.P. Morgan Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $132
J.P. Morgan Remains a Hold on Cardinal Health (CAH)
JPMorgan Adjusts Price Target on Cardinal Health to $132 From $123, Maintains Neutral Rating
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Maintains Target Price $101